• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左乙拉西坦经鼻内和口服给药对 KA 诱导的 SE 大鼠模型中 SV2A 的时空分布的影响。

Effect of intranasal and oral administration of levetiracetam on the temporal and spatial distributions of SV2A in the KA-induced rat model of SE.

机构信息

Department of Neurology, The First Hospital of Jilin University, Jilin University, Changchun, China.

Department of Neurology, Qingdao Women and Children's Hospital of Qingdao University, Qingdao University, Qingdao, China.

出版信息

J Cell Mol Med. 2023 Dec;27(24):4045-4055. doi: 10.1111/jcmm.17986. Epub 2023 Oct 16.

DOI:10.1111/jcmm.17986
PMID:37845841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10746941/
Abstract

To investigate the effectiveness of nasal delivery of levetiracetam (LEV) on the distributions of synaptic vesicle protein 2 isoform A (SV2A) in epileptic rats with injection of kainic acid (KA) into amygdala. A total of 138 rats were randomly divided into four groups, including the Sham surgery group, the epilepsy group (EP), and the LEV oral administration (LPO) and nasal delivery (LND) groups. The rat intra-amygdala KA model of epilepsy was constructed. Pathological changes of rat brain tissue after status epilepticus (SE) were detected using haematoxylin and eosin staining. Expression of SV2A in rat hippocampus after SE was evaluated using the western blotting analysis. Expression and distribution of SV2A in rat hippocampus after SE were detected based on immunofluorescence staining. The EP group showed evident cell loss and tissue necrosis in the CA3 area of hippocampus, whereas the tissue damage in both LPO and LND groups was significantly reduced. Western blotting analysis showed that the expressions of SV2A in the hippocampus of both EP and LND groups were significantly decreased 1 week after SE, increased to the similar levels of the Sham group in 2 weeks, and continuously increased 4 weeks after SE to the level significantly higher than that of the Sham group. Results of immunofluorescence revealed largely the same expression patterns of SV2A in the CA3 area of hippocampus as those in the entire hippocampus. Our study revealed the same antiepileptic and neuronal protective effects by the nasal and oral administrations of LEV, without changing the expression level of SV2A.

摘要

为了研究鼻腔给予左乙拉西坦(LEV)对侧脑室注射红藻氨酸(KA)致痫大鼠突触囊泡蛋白 2 同工型 A(SV2A)分布的影响。将 138 只大鼠随机分为假手术组、癫痫组(EP)、LEV 口服(LPO)组和鼻腔给药(LND)组,每组 39 只。建立大鼠杏仁核 KA 癫痫模型,HE 染色观察 SE 后大鼠脑组织的病理变化,Western blot 检测 SE 后大鼠海马 SV2A 的表达,免疫荧光检测 SV2A 在大鼠海马的表达和分布。EP 组大鼠海马 CA3 区可见明显的细胞丢失和组织坏死,LPO 和 LND 组大鼠脑组织损伤明显减轻。Western blot 分析显示,SE 后 1 周 EP 和 LND 组大鼠海马 SV2A 表达明显降低,2 周时升高至与假手术组相似水平,4 周时持续升高至明显高于假手术组水平。免疫荧光结果显示,SV2A 在海马 CA3 区的表达与全海马具有相似的表达模式。本研究表明,LEV 经鼻腔和口服给药具有相同的抗癫痫和神经元保护作用,不改变 SV2A 的表达水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3835/10746941/eac4f4de9f81/JCMM-27-4045-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3835/10746941/05b0bd64b8a2/JCMM-27-4045-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3835/10746941/0b4555a392be/JCMM-27-4045-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3835/10746941/5cae8ef75770/JCMM-27-4045-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3835/10746941/70f67ac4d1ad/JCMM-27-4045-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3835/10746941/13318faf1126/JCMM-27-4045-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3835/10746941/eac4f4de9f81/JCMM-27-4045-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3835/10746941/05b0bd64b8a2/JCMM-27-4045-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3835/10746941/0b4555a392be/JCMM-27-4045-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3835/10746941/5cae8ef75770/JCMM-27-4045-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3835/10746941/70f67ac4d1ad/JCMM-27-4045-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3835/10746941/13318faf1126/JCMM-27-4045-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3835/10746941/eac4f4de9f81/JCMM-27-4045-g006.jpg

相似文献

1
Effect of intranasal and oral administration of levetiracetam on the temporal and spatial distributions of SV2A in the KA-induced rat model of SE.左乙拉西坦经鼻内和口服给药对 KA 诱导的 SE 大鼠模型中 SV2A 的时空分布的影响。
J Cell Mol Med. 2023 Dec;27(24):4045-4055. doi: 10.1111/jcmm.17986. Epub 2023 Oct 16.
2
Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy.在癫痫发生和慢性癫痫期间,左乙拉西坦结合位点突触囊泡蛋白2A的表达降低。
Epilepsia. 2009 Mar;50(3):422-33. doi: 10.1111/j.1528-1167.2008.01727.x. Epub 2008 Aug 19.
3
Temporal and spatial changes in synaptic vesicle glycoprotein 2A (SV2A) under kainic acid induced epileptogenesis: An autoradiographic study.在海人酸诱导的癫痫发生过程中突触小泡糖蛋白 2A(SV2A)的时空变化:放射自显影研究。
Epilepsy Res. 2022 Jul;183:106926. doi: 10.1016/j.eplepsyres.2022.106926. Epub 2022 Apr 21.
4
Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model.在临床前模型中,布立西坦与左乙拉西坦相比具有良好的不良反应特征。
Epilepsy Behav. 2018 Feb;79:117-125. doi: 10.1016/j.yebeh.2017.11.019. Epub 2017 Dec 26.
5
Association of synaptic density and cognitive performance in temporal lobe epilepsy: Humans and animals PET imaging study with [F]SynVesT-1.颞叶癫痫患者突触密度与认知表现的相关性:[F]SynVesT-1 的人类和动物正电子发射断层扫描研究。
Psychiatry Clin Neurosci. 2024 Aug;78(8):456-467. doi: 10.1111/pcn.13682. Epub 2024 May 28.
6
Spatio-Temporal Alterations in Synaptic Density During Epileptogenesis in the Rat Brain.癫痫发生过程中大鼠脑内突触密度的时空变化。
Neuroscience. 2022 Sep 1;499:142-151. doi: 10.1016/j.neuroscience.2022.07.020. Epub 2022 Jul 22.
7
Differential expression of synaptic vesicle protein 2A after status epilepticus and during epilepsy in a lithium-pilocarpine model.锂-匹罗卡品模型中癫痫持续状态后及癫痫发作期间突触囊泡蛋白2A的差异表达
Epilepsy Behav. 2018 Nov;88:283-294. doi: 10.1016/j.yebeh.2018.08.023. Epub 2018 Oct 15.
8
[Expression of multidrug resistance gene and topiramate affect expression of multidrug resistance gene in the hippocampus of spontaneous epileptic rats].[多药耐药基因的表达及托吡酯对自发性癫痫大鼠海马多药耐药基因表达的影响]
Zhonghua Er Ke Za Zhi. 2005 Oct;43(10):733-7.
9
Antiepileptic effects of levetiracetam in a rodent neonatal seizure model.左乙拉西坦在啮齿动物新生期癫痫发作模型中的抗癫痫作用。
Pediatr Res. 2013 Jan;73(1):24-30. doi: 10.1038/pr.2012.151. Epub 2012 Nov 8.
10
No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy.常见的突触小泡蛋白2A(SV2A)变异在癫痫易感性或左乙拉西坦反应中无主要作用。
Epilepsy Res. 2009 Jan;83(1):44-51. doi: 10.1016/j.eplepsyres.2008.09.003. Epub 2008 Oct 31.

引用本文的文献

1
Targeted lipidomics analysis of possible molecular mechanisms of lipid changes in temporal lobe epilepsy models.颞叶癫痫模型中脂质变化可能分子机制的靶向脂质组学分析
Front Pharmacol. 2025 Jan 9;15:1531524. doi: 10.3389/fphar.2024.1531524. eCollection 2024.

本文引用的文献

1
Parthanatos participates in glutamate-mediated HT22 cell injury and hippocampal neuronal death in kainic acid-induced status epilepticus rats.细胞发生 Parthanatos 参与了海人酸诱导癫痫持续状态大鼠中谷氨酸介导的 HT22 细胞损伤和海马神经元死亡。
CNS Neurosci Ther. 2022 Dec;28(12):2032-2043. doi: 10.1111/cns.13934. Epub 2022 Jul 31.
2
Expression profile of synaptic vesicle glycoprotein 2A, B, and C paralogues in temporal neocortex tissue from patients with temporal lobe epilepsy (TLE).突触小泡糖蛋白 2A、B、C 异构体在颞叶癫痫(TLE)患者颞叶皮质组织中的表达谱。
Mol Brain. 2022 May 16;15(1):45. doi: 10.1186/s13041-022-00931-w.
3
Bioavailability and Safety of a New Highly Concentrated Midazolam Nasal Spray Compared to Buccal and Intravenous Midazolam Treatment in Chinese Healthy Volunteers.
新型高浓度咪达唑仑鼻喷雾剂与咪达唑仑口腔和静脉注射治疗在中国健康志愿者中的生物利用度和安全性比较。
Neurol Ther. 2022 Jun;11(2):621-632. doi: 10.1007/s40120-022-00329-9. Epub 2022 Feb 7.
4
Nose-to-brain delivery of levetiracetam after intranasal administration to mice.经鼻腔给予后,左乙拉西坦在小鼠体内的鼻内递药。
Int J Pharm. 2019 Jun 10;564:329-339. doi: 10.1016/j.ijpharm.2019.04.047. Epub 2019 Apr 20.
5
Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.布立西坦:一种用于癫痫治疗的选择性突触囊泡蛋白2A(SV2A)配体的发现原理及临床前研究概况
Epilepsia. 2016 Apr;57(4):538-48. doi: 10.1111/epi.13340. Epub 2016 Feb 26.
6
Seizures and epilepsy: an overview for neuroscientists.癫痫发作与癫痫:神经科学家概述
Cold Spring Harb Perspect Med. 2015 Jun 1;5(6):a022426. doi: 10.1101/cshperspect.a022426.
7
Development of carbamazepine transnasal microemulsion for treatment of epilepsy.卡马西平经鼻微乳制剂的研制及其在癫痫治疗中的应用。
Drug Deliv Transl Res. 2013 Jun;3(3):252-9. doi: 10.1007/s13346-012-0126-7.
8
Quantitative analysis of drug delivery to the brain via nasal route.经鼻给药递送至脑内的定量分析。
J Control Release. 2014 Sep 10;189:133-40. doi: 10.1016/j.jconrel.2014.06.053. Epub 2014 Jul 3.
9
Intranasal administration of carbamazepine to mice: a direct delivery pathway for brain targeting.对小鼠进行卡马西平鼻内给药:一种脑靶向直接递送途径。
Eur J Pharm Sci. 2014 Aug 18;60:32-9. doi: 10.1016/j.ejps.2014.04.019. Epub 2014 May 9.
10
Intranasal delivery of biologics to the central nervous system.经鼻内递送至中枢神经系统的生物制剂。
Adv Drug Deliv Rev. 2012 May 15;64(7):614-28. doi: 10.1016/j.addr.2011.11.002. Epub 2011 Nov 15.